Social Convoy Palliative Care (Convoy-Pal) Mobile Health for Older Adults (ConvoyPal)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04779931 |
|
Recruitment Status :
Recruiting
First Posted : March 3, 2021
Last Update Posted : April 29, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Chronic Conditions, Multiple | Behavioral: Convoy-Pal | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Estimated Enrollment : | 40 participants |
| Allocation: | Randomized |
| Intervention Model: | Single Group Assignment |
| Masking: | None (Open Label) |
| Primary Purpose: | Health Services Research |
| Official Title: | The Usability and Feasibility of Social Convoy Palliative Care (Convoy-Pal) Mobile Health for Older Adults |
| Actual Study Start Date : | April 1, 2021 |
| Estimated Primary Completion Date : | February 28, 2023 |
| Estimated Study Completion Date : | February 28, 2023 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: Convoy-Pal Intervention
Intervention participants will be sent Convoy-Pal equipment and materials. The equipment can simply be removed from the box, plugged in, and turned on to start. Research staff will provide technical support as needed during the trial. Convoy-Pal is 12-week intervention that uses the Routinify platform to deliver self-management tools and palliative care resources in the participants' home. The platform includes a tablet, charging stand, and smart watch, with additional options for mobile phone access and a website portal.
|
Behavioral: Convoy-Pal
12 week mobile self-management intervention with palliative care resources. |
|
Active Comparator: Waitlist Control
Participants will complete baseline assessments and will be recontacted at 11 weeks to complete follow up assessments at week 12. Participants will receive a $25 gift card for each assessment ($50 total). If they would like to try the intervention at that time, we will send them Convoy-Pal equipment and materials. They will then have 12 weeks to use the tool.
|
Behavioral: Convoy-Pal
12 week mobile self-management intervention with palliative care resources. |
- User Mobile Application Rating Scale [ Time Frame: 12 weeks ]Usability; 20 items; Range 0-25, Higher score indicates better usability
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 65 Years and older (Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- ≥65 years of age
- self-report diagnosis of heart failure (HF)
- have multiple chronic conditions (MCC) based on the Disease Burden/Morbidity Assessment by Self-Report (Individuals will be eligible if they self-report the number of diagnosis > 2 and a disease burden score >2 indicating the presence of at least two chronic conditions that limit activities of daily of living)
- community dwelling in the United States
- English speaking
Exclusion Criteria:
- Self-reported diagnosis of Alzheimer's disease or dementia
- Self-reported diagnosis of a severe mental health problem (e.g. schizophrenia, bipolar affective disorder or other psychotic illness)
- Participation in community-based palliative care in the last 12 months
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04779931
| Contact: Jennifer Portz, PhD, MSW | (303) 724-4438 | Jennifer.portz@cuanschutz.edu |
| United States, Colorado | |
| University of Colorado | Recruiting |
| Aurora, Colorado, United States, 80045 | |
| Contact: Jennifer D Portz, PhD Jennifer.portz@cuanschutz.edu | |
| Principal Investigator: | Jennifer D Portz, PhD, MSW | University of Colorado Denver | Anschutz |
| Responsible Party: | University of Colorado, Denver |
| ClinicalTrials.gov Identifier: | NCT04779931 |
| Other Study ID Numbers: |
18-0973 K76AG059934 ( U.S. NIH Grant/Contract ) |
| First Posted: | March 3, 2021 Key Record Dates |
| Last Update Posted: | April 29, 2021 |
| Last Verified: | April 2021 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Multiple Chronic Conditions Chronic Disease Disease Attributes Pathologic Processes |

